Unsalaried advisory positions  

Hans Clevers is advisor/guest researcher at the Hubrecht Institute and the Princess Máxima Center for Pediatric Oncology and Oncode Investigator, all in Utrecht, NL. He also is University Professor at Utrecht University.

Clevers is inventor on multiple organoid patents, licensed by the KNAW to the Foundation HUB in Utrecht. He holds stock in several biotech companies based on prior Scientific Advisory Board positions, notably Xilis, Kallyope and Surrozen in the USA, and D1Med in China.

He also fills rotating positions in international ‘Learned Societies’ (e.g. ISSCR, AACR), Award Juries (e.g. Francqui Prize, Brussels; Breakthrough Prize, San Francisco, WLA Prize, Shanghai) and in Scientific Advisory Boards (SABs) of the Crick Institute in London).

Current position

Since March 2022, Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland.